65 related articles for article (PubMed ID: 19532009)
1. Nonsmall cell lung cancer in never smokers.
Scagliotti GV; Longo M; Novello S
Curr Opin Oncol; 2009 Mar; 21(2):99-104. PubMed ID: 19532009
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer in never smokers-the East Asian experience.
Zhou F; Zhou C
Transl Lung Cancer Res; 2018 Aug; 7(4):450-463. PubMed ID: 30225210
[TBL] [Abstract][Full Text] [Related]
3. The influence of Hispanic ethnicity on nonsmall cell lung cancer histology and patient survival : an analysis of the surveillance, epidemiology, and end results database.
Gomez SL; Schupp CW; Patel M
Cancer; 2013 Mar; 119(6):1286-7. PubMed ID: 23027432
[No Abstract] [Full Text] [Related]
4. Epigenetic clock as the new hand of time for lung cancer in never smokers.
Christiani DC
Thorax; 2024 Jun; ():. PubMed ID: 38702189
[No Abstract] [Full Text] [Related]
5. Never just one.
Ro GS
J Am Geriatr Soc; 2024 Mar; 72(3):922-923. PubMed ID: 37515492
[No Abstract] [Full Text] [Related]
6. [How often is never?].
Røislien J; Hesselberg JO
Tidsskr Nor Laegeforen; 2023 Dec; 143(18):. PubMed ID: 38088290
[No Abstract] [Full Text] [Related]
7. Research 2021: never the same again.
Toh CH; Stewart P
Future Healthc J; 2021 Jul; 8(2):e187. PubMed ID: 34286182
[No Abstract] [Full Text] [Related]
8. Lung cancer in never smokers: clinical epidemiology and environmental risk factors.
Samet JM; Avila-Tang E; Boffetta P; Hannan LM; Olivo-Marston S; Thun MJ; Rudin CM
Clin Cancer Res; 2009 Sep; 15(18):5626-45. PubMed ID: 19755391
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer in never smokers: molecular profiles and therapeutic implications.
Rudin CM; Avila-Tang E; Harris CC; Herman JG; Hirsch FR; Pao W; Schwartz AG; Vahakangas KH; Samet JM
Clin Cancer Res; 2009 Sep; 15(18):5646-61. PubMed ID: 19755392
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer in never smokers--a review.
Couraud S; Zalcman G; Milleron B; Morin F; Souquet PJ
Eur J Cancer; 2012 Jun; 48(9):1299-311. PubMed ID: 22464348
[TBL] [Abstract][Full Text] [Related]
11. Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review.
Chen X; Liu Y; Røe OD; Qian Y; Guo R; Zhu L; Yin Y; Shu Y
PLoS One; 2013; 8(3):e59314. PubMed ID: 23555654
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population.
Vallabhaneni E; Kareff SA; Barnett RM; Drusbosky LM; Dalal S; Raez LE; Santos ES; Albrecht F; Cusnir M; Rodriguez E
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539485
[TBL] [Abstract][Full Text] [Related]
13. Social and Biological Determinants in Lung Cancer Disparity.
Brock BA; Mir H; Flenaugh EL; Oprea-Ilies G; Singh R; Singh S
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339362
[TBL] [Abstract][Full Text] [Related]
14. Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer.
Xu J; Xu W; Choi J; Brhane Y; Christiani DC; Kothari J; McKay J; Field JK; Davies MPA; Liu G; Amos CI; Hung RJ; Briollais L
PLoS Genet; 2023 Sep; 19(9):e1010902. PubMed ID: 37738239
[TBL] [Abstract][Full Text] [Related]
15. Lung Cancer Risk Prediction Nomogram in Nonsmoking Chinese Women: Retrospective Cross-sectional Cohort Study.
Guo L; Meng Q; Zheng L; Chen Q; Liu Y; Xu H; Kang R; Zhang L; Liu S; Sun X; Zhang S
JMIR Public Health Surveill; 2023 Jan; 9():e41640. PubMed ID: 36607729
[TBL] [Abstract][Full Text] [Related]
16. Distribution and concordance of PD-L1 expression by routine 22C3 assays in East-Asian patients with non-small cell lung cancer.
Fu F; Deng C; Sun W; Zheng Q; Jin Y; Li Y; Zhang Y; Chen H
Respir Res; 2022 Nov; 23(1):302. PubMed ID: 36335353
[TBL] [Abstract][Full Text] [Related]
17. Chinese never smokers with adenocarcinoma of the lung are younger and have fewer lymph node metastases than smokers.
Shan L; Zhang L; Zhu X; Wang Z; Fang S; Lin J; Wang J; Li N; Liu H; Zhang X; Feng Y; Liu J; Pan J; Ye G; Yu X; Tufman A; Katalinic A; Goldmann T; Petersen F; Jiang J; Geng G; Yu X
Respir Res; 2022 Oct; 23(1):293. PubMed ID: 36309662
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy.
de Alencar VTL; Figueiredo AB; Corassa M; Gollob KJ; Cordeiro de Lima VC
Front Immunol; 2022; 13():984349. PubMed ID: 36091058
[TBL] [Abstract][Full Text] [Related]
19. Lung Cancer Biomarker Speak: Teach Me the Language.
Sandy B; Morrissette J
J Adv Pract Oncol; 2022 Apr; 13(3):302-305. PubMed ID: 35663172
[TBL] [Abstract][Full Text] [Related]
20. Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma.
Mack PC; Klein MI; Ayers KL; Zhou X; Guin S; Fink M; Rossi M; Ai-Kateb H; O'Connell T; Hantash FM; Oh WK; Newman S; Schadt EE; Chen R; Hirsch FR
Oncologist; 2022 Jun; 27(6):476-486. PubMed ID: 35298662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
